The State of Michigan’s Department of Licensing and Regulatory Affairs and the Bureau of Medical Marihuana Regulation has opened public comment on a number of medical conditions and treatments that are being considered for addition to the state’s medical marijuana policy.
Public comment will remain open and can be emailed up to 5:00 p.m. on May 3, 2018. You must put “Medical Marihuana Review Panel” in the subject line.
The conditions under consideration are: Anxiety, Depression, Obsessive Compulsive Disorder, Panic attacks, Schizophrenia, Social Anxiety Disorder, Arthritis, Rheumatoid Arthritis, Brain injury, Spinal cord injury, Asthma, Diabetes, Colitis, Gastric Ulcer, Inflammatory Bowel Disease, Ulcerative Colitis, Organ transplant, non-severe and non-chronic pain, Parkinson’s, Tourette’s Syndrome, Autism and Chronic pain.
A public hearing will be held on May 4, during which the Review Panel will make recommendations to the Department Director. It will be held at 9:00 a.m. in the Williams Building 1st Floor Auditorium at 525 W Ottawa St, Lansing, MI 48933.
The current list of debilitating medical conditions covered under Michigan’s Medical Marijuana law include:
Post-Traumatic Stress Disorder Positive status for Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome Hepatitis C Amyotrophic Lateral Sclerosis Crohn’s Disease Agitation of Alzheimer’s disease Nail Patella, or the treatment of these conditions. A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following: Cachexia or Wasting Syndrome Severe and chronic pain Severe nausea Seizures, including but not limited to those characteristic of epilepsy Severe and persistent muscle spasms, including but not limited to those characteristic of multiple sclerosis